Morinamide

Morinamide
Clinical data
ATC code	J04AK04 (WHO) ;
Identifiers
	IUPAC name N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide;
CAS Number	952-54-5;
PubChem CID	70374;
KEGG	D07248 ;
CompTox Dashboard (EPA)	DTXSID4046159 ;
ECHA InfoCard	100.012.237
Chemical and physical data
Formula	C10H14N4O2
Molar mass	222.244 g/mol g·mol−1
	(what is this?) (verify)

Morinamide (or morphazinamide, or morinamid) is a drug used in the treatment of tuberculosis.^[1]

References

^ Bonanni G, Ciccariello M, Mancini P, Pace V, Sagliaschi G (1993). "Concomitant ceco-appendicular and urinary tuberculosis. Description of two rare cases: physiopathological and diagnostic remarks". Riv Eur Sci Med Farmacol. 15 (3–4): 171–4. PMID 7761665.{{cite journal}}: CS1 maint: multiple names: authors list (link)

This antiinfective drug article is a stub. You can help Wikipedia by expanding it.